Her3 Expression News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Her3 Expression. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Her3 Expression Today - Breaking & Trending Today

Patritumab Deruxtecan (HER3-DXd) in EGFR-Mutated NSCLC Following EGFR TKI and Platinum-Based Chemotherapy: HERTHENA-Lung01

Published: October 6, 2023

Expert oncologist Helena Yu, MD, reviews data from HERTHENA-Lung01 following the IASLC 2023 World Conference on Lung Cancer and considers how patritumab deruxtecan will fit into clinical practice.

Source: onclive.com

Related Topics:

Helena YuPatritumab DeruxtecanLung CancerNon Small Cell Lung CancerEgfr MutationEgfr Lung CancerEgfr TkiHerthena Lung01Her3 DxdClinical TrialsNovel TherapyWorld Conference On Lung CancerWclc 20232023 WclcEfficacy DataSafety DataHer3 Membraneh ScoreHer3 ExpressionCns DiseaseIntracranial DiseaseAdverse EventsDrug Adverse Event